Revvity Signals
Harnessing AI for Breakthroughs in Pharma and Biotech
Pages
10
Time to read
16 mins
Publication
Language
English
Pages
10
Time to read
16 mins
Publication
Language
English
This white paper discusses the critical role of data management in leveraging artificial intelligence (AI) and machine learning (ML) for advancements in drug discovery within the pharmaceutical and biotechnology sectors. It outlines how optimizing data management—encompassing the ingestion, storage, organization, and maintenance of data—can enhance the effectiveness of AI methodologies. The paper details various use cases for AI in drug discovery, including target identification, biomarker discovery, and personalized medicine. It emphasizes the importance of high-quality, well-contextualized data for AI to function effectively, highlighting that AI can uncover patterns and insights that may be overlooked by human researchers. Additionally, the paper addresses the challenges organizations face in managing vast datasets and the necessity of incorporating metadata to ensure data is useful for AI applications. The document concludes by stressing that effective data management is essential for maximizing the potential benefits of AI in developing innovative therapies.